The Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment in Breast Cancer Patients

Endocrine therapy is a key treatment strategy to control or eradicate hormone-responsive breast cancer. However, resistance to endocrine therapy leads to breast cancer relapse. The recent extension of adjuvant tamoxifen treatment up to 10 years actualizes the need for identifying biological markers...

Descripción completa

Detalles Bibliográficos
Autores principales: Egeland, Nina G., Lunde, Siri, Jonsdottir, Kristin, Lende, Tone H., Cronin-Fenton, Deirdre, Gilje, Bjørnar, Janssen, Emiel A. M., Søiland, Håvard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632748/
https://www.ncbi.nlm.nih.gov/pubmed/26473850
http://dx.doi.org/10.3390/ijms161024243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632748/
https://www.ncbi.nlm.nih.gov/pubmed/26473850
http://dx.doi.org/10.3390/ijms161024243

Ejemplares similares